Currently holds a position at Novocure Ltd
Position | Company | Period |
---|---|---|
Independent Director | Novocure Ltd | Jan. 1, 2020 - |
Vice Chairman of the Board | Novocure Ltd | None - |
Independent Director | Pernix Therapeutics Holdings Inc | Nov. 21, 2016 - May 1, 2019 |
Independent Director | Albany Molecular Research Inc | Nov. 2, 2010 - Feb. 3, 2016 |
Director | Delcath Systems Inc | Sept. 15, 2014 - Dec. 11, 2014 |
Independent Chairman of the Board | Delcath Systems Inc | Sept. 13, 2013 - Sept. 15, 2014 |
Independent Director | Delcath Systems Inc | March 30, 2011 - Sept. 13, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2021-06-08 | 2021-06-07 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,000
-1.4%
204.55204,550 USD |
1,000 -1.4% | 204.55 | 204,550 USD | |
2021-05-06 | 2021-05-05 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,000
-1.4%
199.67199,670 USD |
1,000 -1.4% | 199.67 | 199,670 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
2,500
-3.4%
200.00500,000 USD |
2,500 -3.4% | 200.00 | 500,000 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
3,500
-4.5%
198.01693,035 USD |
3,500 -4.5% | 198.01 | 693,035 USD | |
2020-09-16 | 2020-09-15 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
7,392
-9.3%
100.00739,200 USD |
7,392 -9.3% | 100.00 | 739,200 USD | |
2020-09-16 | 2020-09-15 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
2,173
-2.9%
100.00217,300 USD |
2,173 -2.9% | 100.00 | 217,300 USD | |
2020-09-16 | 2020-09-14 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
10,000
-12.2%
95.00950,000 USD |
10,000 -12.2% | 95.00 | 950,000 USD | |
2020-09-11 | 2020-09-10 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
10,000
-12.2%
90.00900,000 USD |
10,000 -12.2% | 90.00 | 900,000 USD | |
2020-09-11 | 2020-09-09 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
100
-0.1%
86.068,606 USD |
100 -0.1% | 86.06 | 8,606 USD | |
2020-09-11 | 2020-09-09 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
9,014
-11.1%
85.39769,687 USD |
9,014 -11.1% | 85.39 | 769,687 USD | |
2020-09-04 | 2020-09-02 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
100
-0.1%
85.008,500 USD |
100 -0.1% | 85.00 | 8,500 USD | |
2020-08-27 | 2020-08-25 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
7,112
-9.0%
80.13569,892 USD |
7,112 -9.0% | 80.13 | 569,892 USD | |
2020-08-03 | 2020-07-30 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
7,112
-9.0%
75.00533,400 USD |
7,112 -9.0% | 75.00 | 533,400 USD | |
2020-07-23 | 2020-07-22 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
4,504
-5.9%
67.46303,844 USD |
4,504 -5.9% | 67.46 | 303,844 USD | |
2020-07-23 | 2020-07-22 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
4,573
-5.6%
66.75305,257 USD |
4,573 -5.6% | 66.75 | 305,257 USD | |
2020-07-23 | 2020-07-22 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
423
-0.5%
65.4827,696 USD |
423 -0.5% | 65.48 | 27,696 USD | |
2020-07-23 | 2020-07-21 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
500
-0.7%
65.0732,537 USD |
500 -0.7% | 65.07 | 32,537 USD | |
2019-10-15 | 2019-10-10 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
5,000
-6.7%
72.28361,400 USD |
5,000 -6.7% | 72.28 | 361,400 USD | |
2019-09-12 | 2019-09-10 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
5,000
-6.7%
76.63383,150 USD |
5,000 -6.7% | 76.63 | 383,150 USD | |
2019-07-12 | 2019-07-10 |
Novocure Ltd
(NVCR)
|
S Sale |
5,000
-6.7%
64.83324,155 USD |
5,000 -6.7% | 64.83 | 324,155 USD | |
2019-06-21 | 2019-06-19 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
25,000
-26.5%
60.021,500,500 USD |
25,000 -26.5% | 60.02 | 1,500,500 USD | |
2019-06-12 | 2019-06-10 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
100
-0.1%
55.605,560 USD |
100 -0.1% | 55.60 | 5,560 USD | |
2019-06-12 | 2019-06-10 |
Novocure Ltd
(NVCR)
|
S Sale |
4,900
-6.6%
55.04269,706 USD |
4,900 -6.6% | 55.04 | 269,706 USD | |
2019-05-14 | 2019-05-10 |
Novocure Ltd
(NVCR)
|
S Sale |
5,000
-7.7%
49.79248,950 USD |
5,000 -7.7% | 49.79 | 248,950 USD | |
2019-04-12 | 2019-04-10 |
Novocure Ltd
(NVCR)
|
S Sale |
5,000
-7.7%
45.95229,750 USD |
5,000 -7.7% | 45.95 | 229,750 USD | |
2019-03-12 | 2019-03-11 |
Novocure Ltd
(NVCR)
|
S Sale |
5,000
-7.7%
48.31241,550 USD |
5,000 -7.7% | 48.31 | 241,550 USD | |
2019-03-04 | 2019-03-01 |
Novocure Ltd
(NVCR)
|
S Sale |
25,000
-29.4%
55.011,375,275 USD |
25,000 -29.4% | 55.01 | 1,375,275 USD | |
2019-02-13 | 2019-02-11 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
5,000
-7.7%
49.59247,950 USD |
5,000 -7.7% | 49.59 | 247,950 USD | |
2019-01-28 | 2019-01-25 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
20,000
-25.0%
50.001,000,000 USD |
20,000 -25.0% | 50.00 | 1,000,000 USD | |
2019-01-18 | 2019-01-16 |
Novocure Ltd
(NVCR)
|
S Sale |
20,000
-25.0%
45.00900,060 USD |
20,000 -25.0% | 45.00 | 900,060 USD | |
2019-01-14 | 2019-01-10 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
5,000
-7.7%
39.91199,550 USD |
5,000 -7.7% | 39.91 | 199,550 USD | |
2019-01-11 | 2019-01-09 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
6,726
-10.1%
40.01269,107 USD |
6,726 -10.1% | 40.01 | 269,107 USD | |
2019-01-11 | 2019-01-09 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
13,274
-16.6%
40.00530,960 USD |
13,274 -16.6% | 40.00 | 530,960 USD | |
2004-10-18 | 2004-10-15 |
OSI Pharmaceuticals LLC
(OSIP)
|
PS Planned sale |
378
-3.3%
63.6424,056 USD |
378 -3.3% | 63.64 | 24,056 USD | |
2004-10-18 | 2004-10-15 |
OSI Pharmaceuticals LLC
(OSIP)
|
PS Planned sale |
201
-1.7%
63.6212,788 USD |
201 -1.7% | 63.62 | 12,788 USD | |
2004-10-18 | 2004-10-15 |
OSI Pharmaceuticals LLC
(OSIP)
|
PS Planned sale |
421
-3.5%
63.6026,776 USD |
421 -3.5% | 63.60 | 26,776 USD | |
2004-10-05 | 2004-10-01 |
OSI Pharmaceuticals LLC
(OSIP)
|
PS Planned sale |
2,365
-16.5%
63.00148,995 USD |
2,365 -16.5% | 63.00 | 148,995 USD | |
2004-07-02 | 2004-07-01 |
OSI Pharmaceuticals LLC
(OSIP)
|
PS Planned sale |
2,098
-49.1%
70.01146,888 USD |
2,098 -49.1% | 70.01 | 146,888 USD |